Analyst Scoreboard: 7 Ratings For Hologic
Portfolio Pulse from Benzinga Insights
Over the past three months, 7 analysts have evaluated Hologic (NASDAQ:HOLX), with a mix of bullish and somewhat bullish ratings. Analysts have set a 12-month price target range of $78.00 to $95.00, with an average target of $89.43, reflecting a 6.46% increase from the previous average. Key analysts have recently raised their price targets, indicating positive sentiment towards the stock.
June 27, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hologic (NASDAQ:HOLX) has received a mix of bullish and somewhat bullish ratings from 7 analysts over the past three months. The average 12-month price target has increased to $89.43, reflecting a 6.46% rise from the previous average. Key analysts have raised their price targets, indicating positive sentiment towards the stock.
The increase in the average 12-month price target and the positive sentiment from key analysts suggest a likely short-term upward movement in Hologic's stock price. The raised price targets by multiple analysts indicate confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100